Breaking News

Bilcare Research Invests in Aclar Laminates

March 14, 2016

Invests in a new laminator at its Wilmington, DE facility

Bilcare Research Inc. has invested in a new laminator at its Wilmington, DE facility, allowing the company to offer moisture barrier Aclar laminates for stability packaging, line trial samples, as well as full commercial volumes.  
 
Part of the global Pharmaceutical Packaging Innovation (PPI) Business Unit of Bilcare Research AG, Bilcare Research offers a variety of mono and barrier blister films to the pharmaceutical packaging industry.
 
“This investment in a new laminating line is just the latest component of our continued growth strategy to meet the needs of the rapidly evolving business models of the global pharmaceutical industry.  We see increased demand across our entire range of Bilcare Aclar laminates, from both, ethical and generic pharmaceutical companies,” said Kevin Stevens, president and managing director of Bilcare Research. “The lamination line is a further execution of Bilcare’s strategic investment of €50 Million and is a natural progression to the industry-specific segregation project for our PPI production. The new capacity will be fully available before the end of 2016.”
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks